Please provide your email address to receive an email when new articles are posted on . The FDA approved the Tecnis Eyhance and Tecnis Eyhance toric II IOLs for the treatment of patients with cataract ...

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive ...

Launched in the month of World Sight Day, this next-generation monofocal intraocular lens is an advanced solution for post cataract surgery patients, that helps to meet the changing lifestyle needs of ...

WAXAHACHIE, Texas , March 22, 2021 /PRNewswire/ -- Texas Eye and Cataract (TEC) recently announced that Dr. Deepak Sobti was the first in North Texas to successfully implant the new FDA-approved ...

SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.

First lens (1) in the monofocal IOL category in Europe to deliver improved intermediate vision and 20/20* distance vision TECNIS Eyhance IOL offers the same well-established low incidence of halo, ...

TECNIS Eyhance IOL allows patients to achieve significantly improved intermediate vision, compared with a standard aspheric monofocal IOL, along with 20/20* distance vision. In addition, data has ...

“The Eyhance monofocal IOL was introduced into our practice as a next-generation IOL offering to slightly extend the range of vision for our patients undergoing cataract surgery. However, we observed ...